Total Payments
$1,678
2024 Payments
$287.42
Companies
23
Transactions
107
Payment Breakdown by Category
Food & Beverage$1,678 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,678 | 107 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $277.79 | 20 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $252.82 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $251.40 | 13 | $0 (2024) |
| Novo Nordisk Inc | $210.12 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $156.07 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $115.92 | 8 | $0 (2023) |
| Medtronic, Inc. | $56.49 | 3 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $49.73 | 4 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $37.14 | 2 | $0 (2021) |
| Allergan, Inc. | $36.15 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $287.42 | 15 | AstraZeneca Pharmaceuticals LP ($84.53) |
| 2023 | $290.55 | 17 | GlaxoSmithKline, LLC. ($108.44) |
| 2022 | $247.43 | 16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($71.19) |
| 2021 | $181.06 | 13 | AstraZeneca Pharmaceuticals LP ($71.69) |
| 2020 | $117.80 | 8 | Allergan, Inc. ($36.15) |
| 2019 | $233.22 | 18 | Novo Nordisk Inc ($108.48) |
| 2018 | $197.70 | 13 | Novo Nordisk Inc ($61.26) |
| 2017 | $122.63 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($60.49) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 3 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/12/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Respiratory | ||||||
| 08/04/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2021 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: CARBONIC ANHYDRASE INHIBITOR | ||||||
| 07/13/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2021 | GlaxoSmithKline, LLC. | PEDIARIX (Biological), BEXSERO, SHINGRIX | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: VACCINES | ||||||
| 05/11/2021 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: CARBONIC ANHYDRASE INHIBITOR | ||||||
| 05/07/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Respiratory | ||||||
| 04/29/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: VACCINE | ||||||
| 04/21/2021 | GlaxoSmithKline, LLC. | PEDIARIX (Biological), BEXSERO, SHINGRIX | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: VACCINES | ||||||
| 03/04/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Respiratory | ||||||
| 03/03/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, SHINGRIX | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: VACCINES | ||||||
| 12/03/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX, FLULAVAL QUADRIVALENT | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: VACCINES | ||||||
| 07/23/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: DIABETES | ||||||
| 04/16/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Bone Health | ||||||
| 02/18/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: VACCINES | ||||||
| 01/23/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: DIABETES | ||||||
| 01/09/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 10/10/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Diabetes | ||||||
| 10/02/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, MENVEO | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: VACCINES | ||||||
| 09/12/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 09/12/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: Diabetes | ||||||
| 08/27/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, MENVEO | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: VACCINES | ||||||
| 08/01/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Diabetes | ||||||
About Dr. Breck Richardson, M.D
Dr. Breck Richardson, M.D is a Pediatrics healthcare provider based in Kosciusko, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1962645770.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Breck Richardson, M.D has received a total of $1,678 in payments from pharmaceutical and medical device companies, with $287.42 received in 2024. These payments were reported across 107 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,678).
Ad
Practice Information
- Specialty Pediatrics
- Location Kosciusko, MS
- Active Since 04/08/2009
- Last Updated 12/11/2012
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1962645770
Products in Payments
- BREZTRI (Drug) $252.82
- BEXSERO (Biological) $175.77
- JARDIANCE (Drug) $150.38
- XIFAXAN (Drug) $115.92
- Ozempic (Drug) $84.45
- OFEV (Drug) $73.64
- Tresiba (Drug) $64.41
- AREXVY (Drug) $63.50
- BELSOMRA (Drug) $56.67
- Edarbi (Drug) $49.73
- GARDASIL (Biological) $42.78
- INTELLIS ADAPTIVESTIM (Device) $41.91
- PEDIARIX (Biological) $38.52
- VRAYLAR (Drug) $36.15
- Xultophy 100/3.6 (Drug) $33.11
- Victoza (Drug) $28.15
- GARDASIL 9 (Biological) $27.32
- KEVEYIS (Drug) $24.45
- STIOLTO RESPIMAT (Drug) $22.68
- Kerendia (Drug) $19.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.